Zhuoran R. Yao
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming.
Journal: Signal transduction and targeted therapy
Published: February 13, 2026
Stem-like T cells in cancer immunotherapy: biology, regulation and therapeutic targeting.
Journal: Frontiers in immunology
Published: December 10, 2025
Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of Single-arm Studies.
Journal: International journal of radiation oncology, biology, physics
Published: October 23, 2025
Successful Pregnancy and Healthy Baby Outcome in a Patient With Tyrosine Kinase Inhibitor-Refractory ALK-Positive NSCLC and Central Nervous System Metastasis Treated With Lorlatinib With Maternal-Fetal Pharmacokinetics and Child Milestone Development Correlations.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 29, 2025
Dual-targeting CD133/PD-L1 CAR-T plus αPD-1 overcomes immunosuppressive microenvironment and enhanced by radiation pre-conditioning.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 26, 2025
SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis.
Journal: Nature communications
Published: February 06, 2025
Addressing clinical needs in NSCLC immunotherapy: Mechanisms of resistance and promising combination strategies.
Journal: Cell reports. Medicine
Published: February 03, 2025
Dynamic evolution and antitumor mechanisms of CXCR6+CD8+ T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy.
Journal: Journal of translational medicine
Published: January 23, 2025
Low-dose Radiation Therapy Concurrent With Atezolizumab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: 3-Year Follow-up of a Multicenter, Single-arm, Phase 2 Trial (MATCH).
Journal: International journal of radiation oncology, biology, physics
Published: January 21, 2025
Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment.
Journal: International journal of radiation oncology, biology, physics
Published: December 10, 2024
Nervous system contributions to small cell lung cancer: Lessons from diverse oncological studies.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 27, 2024
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer.
Journal: Translational lung cancer research
Published: January 10, 2024
Last Updated: 09/26/2026